2025 MIDD Webinar Series | Semi-mechanistic PK/PD modeling and simulation of sequential siRNA and bepirovirsen treatment to inform dose selection

Recorded On: 04/16/2025

You must log in to register
- Member - Free!
Continue

The MIDD Webinar Series, coordinated by Yash Kapoor and Fulya Akpinar Singh, is a series of webinars focused on shaping the future of drug development and regulatory decision-making sponsored by the ISoP Education Committee. Topics range from MIDD approaches in regulatory submission to pharmacometrics topics that are at the core of model development.

Nadia Noormohamed

Clinical Pharmacologist

GSK

Nadia is a clinical pharmacologist currently working in the CPMS group at GSK within Vaccines and Infectious Disease. For the past 3 years, she has worked on MIDD approaches in the HBV space, with a focus on PKPD modeling. She has also contributed to internal and external initiatives in the areas of organ impairment and QT prolongation. Nadia had initially trained as a pharmacist and graduated with a PharmD from Massachusetts College of Pharmacy. Research experience while in pharmacy school motivated her to pursue a postdoc in pharmacometrics as part of a combined program with Merck and Rutgers University. After her postdoc and prior to joining GSK in her current role, she continued with Merck in the Pharmacometrics group and gained hands-on experience in various therapeutic areas. Outside of work, Nadia enjoys reading, powerlifting, and perusing different neighborhoods in Philadelphia.